Hidrosis Clinic, Stockholm, Sweden Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2013
NCT01930604
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Carl Swartling

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hyperhidrosis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 3